Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.

Coskun U, Bukan N, Sancak B, Günel N, Ozenirler S, Unal A, Yucel A.

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. Neoplasma.

2004;51(3):209-13. PubMed PMID: 15254675.